Patent Assignment
Reel/Frame 071665/0741
Change of Name
Recorded: 2025-07-10
Pages: 3
Assignor
OREXIA THERAPEUTICS LIMITED
Executed: 2023-04-03
Assignee
CENTESSA PHARMACEUTICALS (OREXIA) LIMITED
3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT, UNITED KINGDOM
Covered Property
(1)
Bicyclic-Heterocycle Derivatives and Their Uses as Orexin-2 Receptor Agonists
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 28, 2023
From: LEFKER, BRUCE
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0738 →
Assignment of Assignor's Interest
Aug 28, 2023
From: HUMPHRIES, PAUL
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0767 →
Assignment of Assignor's Interest
Aug 28, 2023
From: GIBSON, KARL
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0781 →
Assignment of Assignor's Interest
Aug 28, 2023
From: SPENDIFF, MATTHEW; BUCKNELL, SARAH; ZAWODNY, WOJCIECH
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0819 →
Assignment of Assignor's Interest
Aug 28, 2023
From: PORTER, RODERICK
To: OREXIA THERAPEUTICS LIMITED
Reel/Frame 064721/0849 →
Assignment of Assignor's Interest
Oct 20, 2023
From: OREXIA THERAPEUTICS LIMITED
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 065300/0110 →
Security Interest
Dec 31, 2024
From: CENTESSA PHARMACEUTICALS (UK) LIMITED
To: OXFORD FINANCE LLC
Reel/Frame 069708/0039 →
Release of Security Interest
Jun 24, 2026
From: OXFORD FINANCE LLC
To: CENTESSA PHARMACEUTICALS (UK) LIMITED
Reel/Frame 075069/0879 →